NCT05462457View on ClinicalTrials.gov

TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2032

Conditions
Breast CancerNode-positive Breast Cancer
Interventions
PROCEDURE

Targeted axilllary dissection (TAD) followed by axillary lymph node dissection (ALND)

Intraoperative excision of TAD lymph nodes followed by ALND in the same surgical session or secondary surgical intervention

Trial Locations (1)

45136

RECRUITING

Kliniken Essen-Mitte (KEM), Essen

All Listed Sponsors
lead

Kliniken Essen-Mitte

OTHER